ICT&health November 4, 2025
Cutting-edge advances in 3D bioprinting, organoids, and organ-on-a-chip systems are redefining how researchers study, detect, and ultimately prevent cancer. Scientists from the Oregon Health & Science University (OHSU) Knight Cancer Institute and partner institutions have published a new review highlighting how these New Approach Methodologies (NAMs) are revolutionizing cancer research by enabling earlier detection and more personalized treatments.
NAMs combine human-relevant technologies such as organoids, lab-grown tissues, organs-on-a-chip, and computational models. These systems replicate key biological processes, offering an unprecedented view into how cancer originates and evolves, without relying on animal testing. “Early detection is one of the most important factors in surviving cancer,” said Prof. Luiz Bertassoni, Ph.D., Director of the Knight Cancer Precision Biofabrication Hub. “These technologies allow...
Today's Sponsors
Today's Sponsor